Decision-Making in Clinical Investigations and Referrals

Investigations should be conducted only when the result is likely to change patient management in a meaningful way.
Basic, low-risk, and high-yield investigations include: * Urinalysis with culture. * Assessment of post-void residual ( $PVR$ ) volume. * Bladder diaries.

Renal tract imaging, such as ultrasound, is a selective problem-solving tool rather than a routine screening test.
Specific indications for imaging include: * Chronic or significant urinary retention or persistently elevated $PVR$ . * Recurrent urinary tract infections with potential obstruction. * Hematuria or suspected upper urinary tract involvement. * Long-standing voiding dysfunction or concerns regarding hydronephrosis and upper tract dilatation.

Specialist input is appropriate under the following conditions: * The diagnosis remains unclear or there is discordance between symptoms and investigations. * Symptoms are severe, progressive, or atypical. * Conservative and medical management have failed. * Invasive or procedural treatments are under consideration. * History of pelvic or continence surgery or known neurological disease. * Complications such as persistent retention or renal concerns arise.

In patients with significant cognitive impairment or frailty, further investigation may be burdensome without altering management.
Decisions should be guided by functional status, comorbidity burden, life expectancy, and patient goals.
Goals often shift toward symptom reduction, comfort, dignity, and maintaining the patient at home rather than seeking a definitive diagnosis.

Management Change: Investigate only when the result is likely to alter the treatment plan.
Specialist Value: Refer when specialist input is likely to add tangible value to care.
Clinical Restraint: In frail or cognitively impaired patients, restraint is often considered good medicine.